[Chinese expert consensus on ocular chronic graft-versus-host disease (2023)].
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2023 Jun 14;44(6):449-457. doi: 10.3760/cma.j.issn.0253-2727.2023.06.002.
Abstract
摘要
相似文献
1
[Chinese expert consensus on ocular chronic graft-versus-host disease (2023)].《中国眼部慢性移植物抗宿主病专家共识（2023年）》
Zhonghua Xue Ye Xue Za Zhi. 2023 Jun 14;44(6):449-457. doi: 10.3760/cma.j.issn.0253-2727.2023.06.002.
2
[Lung transplantation for chronic graft-versus-host disease after hematopoietic stem cell transplantation].造血干细胞移植后慢性移植物抗宿主病的肺移植
Rev Mal Respir. 2023 Mar;40 Suppl 1:e69-e72. doi: 10.1016/j.rmr.2022.12.009. Epub 2023 Jan 20.
3
Predictive models for ocular chronic graft-versus-host disease diagnosis and disease activity in transplant clinical practice.移植临床实践中眼部慢性移植物抗宿主病诊断及疾病活动度的预测模型
Haematologica. 2015 Sep;100(9):1228-36. doi: 10.3324/haematol.2015.124131. Epub 2015 Jun 18.
4
Patient-reported treatment response in chronic graft--host disease.慢性移植物抗宿主病中患者报告的治疗反应
Haematologica. 2024 Jan 1;109(1):11-12. doi: 10.3324/haematol.2023.283524.
5
Durable discontinuation of systemic therapy for chronic graft--host disease: myth or reality?慢性移植物抗宿主病全身治疗的持久停药：神话还是现实？
Haematologica. 2023 Feb 1;108(2):303-305. doi: 10.3324/haematol.2022.281114.
6
ANZTCT consensus position statement on ruxolitinib in steroid-refractory acute and chronic graft-versus-host disease.ANZTCT 共识立场声明：芦可替尼治疗激素难治性急性和慢性移植物抗宿主病。
Intern Med J. 2023 Dec;53(12):2319-2329. doi: 10.1111/imj.16255. Epub 2023 Nov 28.
7
Case series: CYP Inhibition and low dose ibrutinib for steroid-refractory chronic graft-versus-host disease.病例系列：CYP抑制与低剂量伊布替尼治疗类固醇难治性慢性移植物抗宿主病
Br J Haematol. 2023 May;201(3):573-576. doi: 10.1111/bjh.18712. Epub 2023 Mar 1.
8
Ocular graft-versus-host disease (oGVHD): From A to Z.眼移植物抗宿主病（oGVHD）：从 A 到 Z。
Surv Ophthalmol. 2023 Jul-Aug;68(4):697-712. doi: 10.1016/j.survophthal.2023.02.006. Epub 2023 Mar 2.
9
Current insights into ocular graft-versus-host disease.当前对眼移植物抗宿主病的认识。
Curr Opin Ophthalmol. 2010 Nov;21(6):485-94. doi: 10.1097/ICU.0b013e32833eab64.
10
Severe relapses of cutaneous T-cell lymphoma after treatment of chronic graft-versus-host disease with ruxolitinib.用鲁索替尼治疗慢性移植物抗宿主病后皮肤T细胞淋巴瘤的严重复发
J Eur Acad Dermatol Venereol. 2024 Jan;38(1):e32-e34. doi: 10.1111/jdv.19408. Epub 2023 Aug 23.
引用本文的文献
1
Safety and efficacy of human amniotic epithelial stem cell eye drops in ocular chronic graft--host disease.人羊膜上皮干细胞滴眼液治疗眼部慢性移植物抗宿主病的安全性和有效性
Haematologica. 2025 Feb 1;110(2):470-474. doi: 10.3324/haematol.2023.284571.
本文引用的文献
1
Recent advances in ocular graft-versus-host disease.眼移植物抗宿主病的最新进展。
Front Immunol. 2023 Jan 25;14:1092108. doi: 10.3389/fimmu.2023.1092108. eCollection 2023.
2
[Treatment of chronic ocular graft versus host disease].[慢性眼部移植物抗宿主病的治疗]
Zhonghua Xue Ye Xue Za Zhi. 2022 Oct 14;43(10):877-880. doi: 10.3760/cma.j.issn.0253-2727.2022.10.015.
3
Haematopoietic stem-cell transplantation in China in the era of targeted therapies: current advances, challenges, and future directions.中国靶向治疗时代的造血干细胞移植：当前的进展、挑战和未来方向。
Lancet Haematol. 2022 Dec;9(12):e919-e929. doi: 10.1016/S2352-3026(22)00293-9.
4
Meibomian Gland Dysfunction: A Route of Ocular Graft-Versus-Host Disease Progression That Drives a Vicious Cycle of Ocular Surface Inflammatory Damage.睑板腺功能障碍：眼移植物抗宿主病进展的途径，导致眼表面炎症损伤的恶性循环。
Am J Ophthalmol. 2023 Mar;247:42-60. doi: 10.1016/j.ajo.2022.09.009. Epub 2022 Sep 23.
5
Posterior segment complications and the risk factors after allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后后节段并发症及相关危险因素。
Eye (Lond). 2023 Jun;37(9):1816-1821. doi: 10.1038/s41433-022-02250-9. Epub 2022 Sep 17.
6
Ocular surface disease index questionnaire as a sensitive test for primary screening of chronic ocular graft-versus-host disease.眼表疾病指数问卷作为慢性眼部移植物抗宿主病初步筛查的敏感检测方法。
Ann Transl Med. 2022 Aug;10(16):855. doi: 10.21037/atm-21-6946.
7
Vision-specific and cancer-specific quality of life in ocular graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后眼部移植物抗宿主病中特定视力和特定癌症的生活质量
Graefes Arch Clin Exp Ophthalmol. 2023 Feb;261(2):453-465. doi: 10.1007/s00417-022-05812-5. Epub 2022 Aug 27.
8
Biomarkers in Ocular Graft-Versus-Host Disease: Implications for the Involvement of B Cells.眼移植物抗宿主病的生物标志物：B 细胞参与的意义。
Transplant Cell Ther. 2022 Nov;28(11):749.e1-749.e7. doi: 10.1016/j.jtct.2022.07.023. Epub 2022 Jul 29.
9
Current status and prospects of hematopoietic stem cell transplantation in China.中国造血干细胞移植的现状与展望。
Chin Med J (Engl). 2022 Jun 20;135(12):1394-1403. doi: 10.1097/CM9.0000000000002235.
10
Corneal endothelial cell reduction and increased Neurokinin-1 receptor expression in a graft-versus-host disease preclinical model.角膜内皮细胞减少和神经激肽-1 受体表达增加在移植物抗宿主病临床前模型中。
Exp Eye Res. 2022 Jul;220:109128. doi: 10.1016/j.exer.2022.109128. Epub 2022 May 27.
Zotero 插件